GILEAD SCIENCES ANNOUNCES SECOND QUARTER 2024 ...

Gilead Sciences Announces Second Quarter 2024 Financial Results

Total second quarter 2024 revenue increased 5% to $7.0 billion, compared to the same period in 2023, primarily due to higher product sales in ...

Gilead Sciences to Release Second Quarter 2024 Financial Results ...

Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 ... FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead ...

Gilead Sciences to Release Second Quarter 2024 Financial Results ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results and guidance will be released on ...

Gilead Sciences Announces Second Quarter 2024 Financial Results

The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, ...

Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of 2023.

Gilead Sciences to Release Second Quarter 2024 Financial Results ...

Gilead Sciences (Nasdaq: GILD) has announced that it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after the market ...

Gilead Sciences Announces Third Quarter 2024 Financial Results

Total third quarter 2024 revenue increased 7% to $7.5 billion compared to the same period in 2023, primarily due to higher sales in HIV as well ...

Gilead Sciences Q2 2024 Earnings Conference Call

Gilead Sciences Q2 2024 Earnings Conference Call. Aug 8, 2024 | 4:30 PM ... Quarterly Reports. SEC Filings. End of Day Stock Quote. Events ...

GILEAD SCIENCES ANNOUNCES SECOND QUARTER 2024 ...

Total second quarter 2024 revenue increased 5% to $7.0 billion, compared to the same period in 2023, primarily due to higher product sales in ...

Gilead Sciences to Release Second Quarter 2024 Financial Results ...

FOSTER CITY, Calif., July 25, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results and ...

Gilead Sciences Reports Q2 2024 Financial Results

Gilead Sciences, Inc. announced its financial results for the second quarter of 2024, showcasing a 5% revenue increase to $7.0 billion ...

Gilead Sciences Second Quarter 2024 Earnings: Beats Expectations

Gilead Sciences ( NASDAQ:GILD ) Second Quarter 2024 Results Key Financial Results Revenue: US$6.95b (up 5.4% from 2Q...

Financials - Quarterly Results - Gilead Sciences, Inc.

Q2 2024. Q1 2024. Q4 2023. Select quarter: Q3 2024, Q2 2024, Q1 2024, Q4 2023 ... Quarterly Reports. SEC Filings. End of Day Stock Quote. Events & Presentations ...

Gilead Stock Dips As 'Non-Core' Products Drive Its Second-Quarter ...

Total product sales — which excludes other sources of revenue like royalties — increased 5% to $6.91 billion. Excluding revenue from Covid ...

Gilead Sciences posts higher Q2 profit and revenue on increased ...

The Foster City, Calif., biopharmaceutical company on Thursday reported second-quarter net income of $1.61 billion, $1.29 a share, up from $1.05 billion, or 83 ...

2nd-qtr 2024 Gilead financials beat expectations - The Pharma Letter

US biotech Gilead Sciences announced second quarter 2024 financials after markets closed on Thursday.

Gilead Sciences Q2 2024 Financial Results - TradingView

Gilead Sciences, Inc., a leading biopharmaceutical company, has released its second quarter 2024 financial results.

Gilead Sciences Announces Second Quarter 2024 Financial Results

Gilead Logo Gilead Sciences, Inc. has added a new press release to its website: Gilead Sciences Announces Second Quarter 2024 Financial ...

Gilead Sciences Announces 2.7 Percent Increase in First Quarter ...

The increase will result in a quarterly dividend of $0.77 per share of common stock. The dividend is payable on March 28, 2024, to stockholders of record at the ...

Matthew Policastro on X: "Gilead Sciences @GileadSciences ...

Gilead Sciences @GileadSciences Announces Second Quarter 2024 Financial Results - https://t.co/dRUDN1HQx9.